Q fever: epidemiology, clinical features and prognosis. A study from 1983 to 1999 in the South of Spain

Alarcón, Arı́stides de; Villanueva, José Luis Güell; Viciana, Pompeyo; López‐Cortés, Luis F.; Torronteras, Rafael; Bernabeu, M.; Cordero, Elisa; Pachón, Jerónimo

doi:10.1016/s0163-4453(03)00013-6

Cited by 65 publications

(43 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The most recent cases of Q fever have been described in Australia [50,148,186], Canada [87,94], France [125,165], Germany [58], Japan [160], Spain [34,135], Switzerland and the United Kingdom [117]. Little information is available to explain such an increase of cases of Q fever except perhaps in Bulgaria where the rise of the number of goats that daily go through villages and small towns for grazing is associated with an increase in human Q fever [141].…”

Section: Zoonotic Aspectmentioning

confidence: 99%

“…In other countries such as Australia, California and France [101], hepatitis and isolated or prolonged fever are the most common manifestations. In Spain and particularly in Catalonia [135] and in the Basque country [109,145], atypical pneumonia is mainly reported while in Andalusia [34,90,131] hepatitis and isolated or prolonged fever have been reported. The explanation of such differences is still unknown and could be due to differences of virulence between strains.…”

Section: Emerging/re-emerging Aspectmentioning

confidence: 99%

See 1 more Smart Citation

Is Q Fever an emerging or re-emerging zoonosis?

2005

View full text Add to dashboard Cite

-Q fever is a zoonotic disease considered as emerging or re-emerging in many countries. It is caused by Coxiella burnetii, a bacterium developing spore-like forms that are highly resistant to the environment. The most common animal reservoirs are livestock and the main source of infection is by inhalation of contaminated aerosols. Although the culture process for Coxiella is laborious, advances on the knowledge of the life cycle of the bacterium have been made. New tools have been developed to (i) improve the diagnosis of Q fever in humans and animals, and especially animal shedders, (ii) perform epidemiological studies, and (iii) prevent the disease through the use of vaccines. This review summarizes the state of the knowledge on the bacteriology and clinical manifestations of Q fever as well as its diagnosis, epidemiology, treatment and prevention in order to understand what factors are responsible for its emergence or re-emergence. Coxiella burnetii / epidemiology / bacteriology / diagnostic / control

show abstract

Section: Zoonotic Aspectmentioning

confidence: 99%

Section: Emerging/re-emerging Aspectmentioning

confidence: 99%

Is Q Fever an emerging or re-emerging zoonosis?

2005

View full text Add to dashboard Cite

show abstract

“…The disease is often self-limiting [39]. In endemic regions such as southern Spain, the Basque region and France, fever lasting more than 1 and less than 3 weeks is typical for Q fever [40]. …”

Section: Current Knowledge About the Pathogenmentioning

confidence: 99%

<b><i>Coxiella burnetii</i></b> - Pathogenic Agent of Q (Query) Fever

Dalton¹,

Dreier²,

Rink³

et al. 2013

Transfus Med Hemother

View full text Add to dashboard Cite

“…2 In the south of Spain, 90% of symptomatic patients present with fever of intermediate duration, which is accompanied by hypertransaminasemia in 60% of patients. 3 The most severe clinical forms are endocarditis, vascular prosthesis infections of and aortic aneurysms, which require surgery in 15---73% of patients and cause mortality in 5---65%, depending on whether appropriate treatment is administered. 4---7 Endocarditis and endovascular infections develop after an episode of acute Q fever at rates that vary between 0% and 1.5%, 3,7---9 reaching rates of up to 7% in specialized centers.…”

Section: Introductionmentioning

confidence: 99%